AgeX Therapeutics, Inc. (AGE)

Operating Cash Flow Growth

26.19%

TTM · Period ending:

AGE logo

AGE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported26.19%
AGE TTM Cash from Operations YoY % (-27.08% → 26.19%)
High-resolution chart · PNG

AGE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
26.1917%
26.8596%
18.9024%
-87.8068%
-421.2998%
-231.27%
-183.8462%
-77.5074%
14.7182%
-21.7899%
-31.3352%
-12.8332%
6.8277%
10.1006%
24.3921%
19.9668%
11.7452%
18.1558%
-0.4861%
9.0613%
13.8379%
12.7316%
23.061%
12.1184%
1.2492%
-11.5939%
-27.0794%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.